Literature DB >> 33423785

Development and validation of a novel mail-in semen analysis system and the correlation between one hour and delayed semen analysis testing.

Mary K Samplaski1, Owen Falk2, Stanton Honig3, David Shin4, William Matthews2, James F Smith5.   

Abstract

OBJECTIVE: To develop and validate a novel, mail-in semen analysis (SA) system.
DESIGN: Prospective cohort.
SETTING: Not applicable. PATIENT(S): Ejaculates from normospermic men. INTERVENTION(S): One-hour SA, then repeat SAs (on same ejaculate) over 52 hours using a novel technique for maintaining sperm viability. MAIN OUTCOME MEASURE(S): World Health Organization SA parameters. RESULT(S): One-hour SA on 104 ejaculates in the validation phase of the study demonstrated normal semen parameters. With up to 52 hours of observation and four subsequent SA measurements/ejaculate, concentration remained stable, motility decreased by 0.39%/h, and normal morphology decreased by 0.1%/h. Measured 1-hour and calculated motility (correlation coefficients 0.87) and morphology (correlation coefficients 0.82) strongly were correlated.
CONCLUSION: This novel, mail-in, Clinical Laboratory Improvement Amendments-approved SA testing system demonstrates a strong degree of correlation between 1-hour and delayed SA testing. Given the linear motility and morphology decrease and stability of sperm concentration, this test may be used in clinical practice to evaluate semen quality for fertility evaluations. Furthermore, this approach significantly improves the ease, comfort, and efficiency of obtaining a SA, likely breaking down early barriers to accessing successfully a male fertility evaluation.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Semen analysis; mail-in sperm test; male infertility; social distancing

Year:  2021        PMID: 33423785     DOI: 10.1016/j.fertnstert.2020.10.047

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  The impact of COVID-19 on urology office visits and adoption of telemedicine services.

Authors:  Mohit Butaney; Amarnath Rambhatla
Journal:  Curr Opin Urol       Date:  2022-03-01       Impact factor: 2.309

2.  Potential pitfalls of reproductive direct-to-consumer testing.

Authors:  Frank Z Stanczyk; Rachel S Mandelbaum; Rogerio A Lobo
Journal:  F S Rep       Date:  2022-02-01

Review 3.  Increase in Direct-to-Consumer Telemedicine in Urology.

Authors:  Erin Jesse; Nannan Thirumavalavan; Aram Loeb
Journal:  Curr Sex Health Rep       Date:  2022-08-05

4.  Algorithms for Predicting the Probability of Azoospermia from Follicle Stimulating Hormone: Design and Multi-Institutional External Validation.

Authors:  Michael B Tradewell; Walter Cazzaniga; Rodrigo L Pagani; Rohit Reddy; Luca Boeri; Eliyahu Kresch; Luca A Morgantini; Emad Ibrahim; Craig Niederberger; Andrea Salonia; Ranjith Ramasamy
Journal:  World J Mens Health       Date:  2022-01-27       Impact factor: 6.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.